In vivo Bioequivalence study of Ticagrelor Tablet
Not Applicable
- Conditions
- In the present study, no diseases will be examined and products will be administered by healthy volunteers..
- Registration Number
- IRCT20210519051345N1
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- 24
Inclusion Criteria
Being Healthy without any Heart, liver and kidney diseases
Exclusion Criteria
Having any kind of illnesses
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Plasma Drug Concentration. Timepoint: 0.5-48 hours in predetermined time intervals. Method of measurement: HPLC.
- Secondary Outcome Measures
Name Time Method